Karmanos Cancer Institute at McLaren Flint
Karmanos Cancer Institute at McLaren Flint
Flint, Michigan, United States7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-08-26 | NCT07227831 | |
| Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Recruiting | Phase 2 | 2026-08-10 | NCT06576115 | |
| Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-07-24 | NCT07098299 | |
| ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, malignant epithelial tumor of ovary, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 2 | 2026-06-17 | NCT04055649 | |
| A Study of the TheraBionic P1 Device in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-04-21 | NCT07218432 | |
| TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | Hepatocellular Carcinoma Recurrent | Recruiting | Not applicable | 2026-04-13 | NCT07118202 | |
| Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer | Metastatic Colorectal Adenocarcinoma | Recruiting | Phase 2 | 2025-11-10 | NCT07130903 |